459 related articles for article (PubMed ID: 9229367)
21. The persistence of anticardiolipin antibodies is associated with an increased risk of the presence of lupus anticoagulant and anti-beta2-glycoprotein I antibodies.
Neville C; Rauch J; Kassis J; Solymoss S; Joseph L; Belisle P; Subang R; Chang ER; Fortin PR
Rheumatology (Oxford); 2006 Sep; 45(9):1116-20. PubMed ID: 16510527
[TBL] [Abstract][Full Text] [Related]
22. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
23. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
24. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
Marai I; Levi Y; Godard G; Shoenfeld Y
Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
[TBL] [Abstract][Full Text] [Related]
25. Sudden sensorineural hearing loss in patients with systemic lupus erythematosus or lupus-like syndromes and antiphospholipid antibodies.
Naarendorp M; Spiera H
J Rheumatol; 1998 Mar; 25(3):589-92. PubMed ID: 9517786
[TBL] [Abstract][Full Text] [Related]
26. Epilepsy and antiphospholipid antibodies in systemic lupus erythematosus patients.
Formiga F; Mitjavila F; Pac M; Moga I
Lupus; 1997; 6(5):486. PubMed ID: 9229372
[No Abstract] [Full Text] [Related]
27. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
28. Clinical importance of positive test results for lupus anticoagulant and anticardiolipin antibodies.
Proven A; Bartlett RP; Moder KG; Chang-Miller A; Cardel LK; Heit JA; Homburger HA; Petterson TM; Christianson TJ; Nichols WL
Mayo Clin Proc; 2004 Apr; 79(4):467-75. PubMed ID: 15065611
[TBL] [Abstract][Full Text] [Related]
29. Profiling of non-criteria antiphospholipid antibodies in patients with SLE: differentiation of thrombotic SLE patients and risk of recurrence of thrombosis.
Tkachenko O; Lapin S; Mazing A; Emanuel V; Belolipetskaia E; Beliaeva I; Myachikova V; Maslyansky A; Schierack P; Roggenbuck D
Lupus; 2020 Apr; 29(5):490-498. PubMed ID: 32131675
[TBL] [Abstract][Full Text] [Related]
30. Neurological manifestations of systemic lupus erythematosus: role of antiphospholipid antibodies.
Golstein M; Meyer O; Bourgeois P; Palazzo E; Nicaise P; Labarre C; Kahn MF
Clin Exp Rheumatol; 1993; 11(4):373-9. PubMed ID: 8403581
[TBL] [Abstract][Full Text] [Related]
31. Thrombin generation measured ex vivo following microvascular injury is increased in SLE patients with antiphospholipid-protein antibodies.
Musiał J; Swadźba J; Jankowski M; Grzywacz M; Bazan-Socha S; Szczeklik A
Thromb Haemost; 1997 Oct; 78(4):1173-7. PubMed ID: 9364980
[TBL] [Abstract][Full Text] [Related]
32. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
[TBL] [Abstract][Full Text] [Related]
33. [Significance of antiphospholipid syndrome and antiphospholipid antibodies in patients with systemic lupus erythematosus in estimation of risk of subclinical atherosclerosis development].
Fischer K; Brzosko M; Walecka A; Ostanek L; Sawicki M
Pol Arch Med Wewn; 2007; 117 Suppl():13-7. PubMed ID: 18778013
[TBL] [Abstract][Full Text] [Related]
34. Serum apolipoprotein H levels in systemic lupus erythematosus are not influenced by antiphospholipid antibodies.
Ichikawa Y; Takamatsu K; Shimizu H; Uchiyama M; Moriuchi J; Takaya M; Kobayashi N; Kawada T; Arimori S
Lupus; 1992 May; 1(3):145-9. PubMed ID: 1301975
[TBL] [Abstract][Full Text] [Related]
35. Antiphospholipid antibodies and antiphospholipid syndrome in 57 children and adolescents with systemic lupus erythematosus.
Campos LM; Kiss MH; D'Amico EA; Silva CA
Lupus; 2003; 12(11):820-6. PubMed ID: 14667097
[TBL] [Abstract][Full Text] [Related]
36. [Comparative analysis of clinical and laboratory charactiristics of antiphospholipid syndrome].
Soltész P; Veres K; Kiss E; Lakos G; Sonkoly I; Muszbek L; Szegedi G
Orv Hetil; 2000 Dec; 141(52):2821-5. PubMed ID: 11202118
[TBL] [Abstract][Full Text] [Related]
37. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G
Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
[TBL] [Abstract][Full Text] [Related]
38. Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus.
Demir S; Li J; Magder LS; Petri M
Rheumatology (Oxford); 2021 Aug; 60(8):3770-3777. PubMed ID: 33331921
[TBL] [Abstract][Full Text] [Related]
39. Detection of complement-fixing antiphospholipid antibodies in association with thrombosis.
Munakata Y; Saito T; Matsuda K; Seino J; Shibata S; Sasaki T
Thromb Haemost; 2000 May; 83(5):728-31. PubMed ID: 10823270
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of deep venous thrombosis in the lower limbs and the pelvis and pulmonary embolism in patients with positive antiphospholipid antibodies.
Kinuya K; Kakuda K; Matano S; Sato S; Sugimoto T; Asakura H; Kinuya S; Michigishi T; Tonami N
Ann Nucl Med; 2001 Dec; 15(6):495-7. PubMed ID: 11831396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
